Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11993583 Therapeutic compounds

Patent 11993583 was granted and assigned to Gilead Sciences on May, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Gilead Sciences

0

Current Assignee

Gilead Sciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Dimitrios Stefanidis0

Michael Graupe0

Winston C. Tse0

Jennifer R. Zhang0

John O. Link0

Roland D. Saito0

Scott D. Schroeder0

Date of Patent

May 28, 2024

0

Patent Application Number

166943320

Date Filed

November 25, 2019

0

Patent Citations

US Patent 8748412 Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators

0

US Patent 7390791 Prodrugs of phosphonate nucleotide analogues

0

US Patent 7803788 Prodrugs of phosphonate nucoleotide analogues

0

US Patent 8263627 Pyridyl amide T-type calcium channel antagonists

0

US Patent 9730936 Quinazoline compounds

0

US Patent 9789089 Therapeutic compounds

0

US Patent 9873680 Therapeutic compounds

0

US Patent 9944619 Compounds for the treatment of HIV

0

...

Patent Primary Examiner

Kortney L. Klinkel

0

CPC Code

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11993583 Therapeutic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool